NAICS Code 621511-02 - Blood Tests

Marketing Level - NAICS 8-Digit

Business Lists and Databases Available for Marketing and Research

Total Verified Companies: 33
Contact Emails: 93
Company Websites: 25
Phone Numbers: 28
Business Addresses: 33
Companies with Email: 14
Reach new customers, connect with decision makers, and grow your business.
Pricing from $0.05 to $0.25 per lead

Business List Pricing Tiers

Quantity of Records Price Per Record Estimated Total (Max in Tier)
0 - 1,000 $0.25 Up to $250
1,001 - 2,500 $0.20 Up to $500
2,501 - 10,000 $0.15 Up to $1,500
10,001 - 25,000 $0.12 Up to $3,000
25,001 - 50,000 $0.09 Up to $4,500
50,000+ Contact Us for a Custom Quote

What's Included in Every Standard Data Package

  • Company Name
  • Contact Name (where available)
  • Job Title (where available)
  • Full Business & Mailing Address
  • Business Phone Number
  • Industry Codes (Primary and Secondary SIC & NAICS Codes)
  • Sales Volume
  • Employee Count
  • Website (where available)
  • Years in Business
  • Location Type (HQ, Branch, Subsidiary)
  • Modeled Credit Rating
  • Public / Private Status
  • Latitude / Longitude
  • ...and more (Inquire)

Boost Your Data with Verified Email Leads

Enhance your list or opt for a complete 100% verified email list – all for just $0.10 per email!

Ideal for: Direct Mailing Email Campaigns Calling Market ResearchFree Sample & Report, Custom Lists, and Expert Support — All Included
Looking for more companies? See NAICS 621511 - Medical Laboratories - 11,173 companies, 48,597 emails.

NAICS Code 621511-02 Description (8-Digit)

Blood Tests is a subdivision of the Medical Laboratories industry that involves the analysis of blood samples to diagnose and monitor various medical conditions. This industry plays a crucial role in the healthcare sector by providing accurate and timely information to physicians and other healthcare professionals to aid in the diagnosis and treatment of patients.

Parent Code - Official US Census

Official 6‑digit NAICS codes serve as the parent classification used for government registrations and documentation. The marketing-level 8‑digit codes act as child extensions of these official classifications, providing refined segmentation for more precise targeting and detailed niche insights. Related industries are listed under the parent code, offering a broader context of the industry environment. For further details on the official classification for this industry, please visit the U.S. Census Bureau NAICS Code 621511 page

Tools

Tools commonly used in the Blood Tests industry for day-to-day tasks and operations.

  • Hematology analyzers
  • Blood gas analyzers
  • Coagulation analyzers
  • Chemistry analyzers
  • Microscopes
  • Centrifuges
  • Pipettes
  • Test tubes
  • Needles
  • Lancets
  • Specimen collection containers
  • Blood culture bottles
  • Automated sample processing systems
  • Quality control materials
  • Calibration solutions
  • Reagents
  • Laboratory information management systems (LIMS)
  • Electronic medical record (EMR) systems

Industry Examples of Blood Tests

Common products and services typical of NAICS Code 621511-02, illustrating the main business activities and contributions to the market.

  • Complete blood count (CBC)
  • Blood glucose test
  • Lipid panel
  • Basic metabolic panel (BMP)
  • Comprehensive metabolic panel (CMP)
  • Liver function tests (LFTs)
  • Kidney function tests
  • Thyroid function tests
  • Blood clotting tests
  • Blood typing and crossmatching
  • Infectious disease testing (e.g. HIV, hepatitis)
  • Cancer screening (e.g. prostate-specific antigen, CA-125)
  • Allergy testing
  • Iron studies
  • Vitamin and mineral testing
  • Therapeutic drug monitoring
  • Blood alcohol testing
  • Blood lead testing

History

A concise historical narrative of NAICS Code 621511-02 covering global milestones and recent developments within the United States.

  • The history of the Blood Tests industry dates back to the early 20th century when the first blood test was developed to diagnose syphilis. In the 1940s, the discovery of blood typing and cross-matching revolutionized blood transfusions and made them safer. The 1950s saw the development of the first automated blood cell counter, which allowed for faster and more accurate blood tests. In the 1970s, the first home pregnancy test was introduced, which allowed women to test for pregnancy in the privacy of their own homes. In recent years, the Blood Tests industry has seen significant advancements in technology, such as the development of point-of-care testing devices that allow for faster and more convenient testing. Additionally, the industry has seen an increase in the use of genetic testing, which allows for more personalized and targeted medical treatments. In the United States, the Blood Tests industry has experienced significant growth in recent years due to an aging population and an increase in chronic diseases such as diabetes and heart disease. The industry has also seen an increase in demand for genetic testing, which has become more affordable and accessible to consumers. In 2019, the global market for blood testing was valued at $51.5 billion, with the United States accounting for a significant portion of that market. The COVID-19 pandemic has also had a significant impact on the industry, with an increase in demand for COVID-19 testing leading to a surge in growth for the industry. Overall, the Blood Tests industry has a bright future ahead, with continued advancements in technology and an increasing demand for personalized medical treatments.